Disclosures for "Diagnostic, Treatment, and Follow-up Practice Variation in Encephalitis of Unknown Etiology: The Neuroinfections Emerging in the Americas Study (NEAS) In Colombia"
-
Mr. Jimenez has nothing to disclose.
-
Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
-
Guillermo Gonzalez-Manrique has nothing to disclose.
-
Dr. Acero-Garces has nothing to disclose.
-
Beatriz Parra has nothing to disclose.
-
Lyda Osorio has nothing to disclose.
-
Federico Silva has nothing to disclose.
-
Jairo Lizarazo Niño has nothing to disclose.
-
The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .